Which tumor marker combination is most specific for monitoring treatment response in gestational choriocarcinoma, and what molecular property makes it uniquely elevated in this malignancy compared to normal pregnancy?
- A AFP and CEA; both are embryonic oncoproteins re-expressed by trophoblastic invasion
- B CA 125 and CA 19-9; synthesized by the decidualized endometrium under trophoblast invasion
- C Beta-hCG (hyperglycosylated isoform); malignant syncytiotrophoblasts produce a hyperglycosylated hCG variant that resists pituitary feedback and persists at levels disproportionate to gestational age ✓
- D LDH and alkaline phosphatase; elevated due to placental isoenzyme release from lysed syncytia
Correct answer: C. Beta-hCG (hyperglycosylated isoform); malignant syncytiotrophoblasts produce a hyperglycosylated hCG variant that resists pituitary feedback and persists at levels disproportionate to gestational age
Explanation
Beta-hCG is the definitive marker for gestational trophoblastic disease, including choriocarcinoma. Malignant trophoblasts produce a hyperglycosylated hCG isoform ('invasive trophoblast antigen') with extra oligosaccharide chains that resist degradation by serum proteases and suppress natural killer cell activity, enabling immune escape. Levels in choriocarcinoma can exceed 100,000 mIU/mL, far beyond normal pregnancy levels at equivalent post-conception timing, and serial beta-hCG is used to monitor treatment response and detect relapse.
Reference: Robbins & Cotran Pathologic Basis of Disease, 10th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.